Cerner Corp. (NASDAQ: CERN ) This leading supplier of health care information
technology is in a powerful bull channel that began last November. Analysts
expect revenues to increase 14% in 2011, and they expect similar results in
2012. S&P recently upgraded their opinion to a "four-star buy"
recommendation with a target of $80. They estimate a three-year earnings growth
rate of 24%. CERN made a new high in September at over $74. The recent pullback
to under $66 appears to be an excellent price to purchase shares of this
high-growth investment as a long-term hold or a trade to $75. Click to Enlarge
No comments:
Post a Comment